Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Hepatitis C

  Free Subscription


1 Clin Res Hepatol Gastroenterol
2 Dig Dis Sci
1 Enferm Infecc Microbiol Clin
1 Hepatology
3 J Viral Hepat
3 J Virol
1 Lancet Infect Dis
2 PLoS One
2 Proc Natl Acad Sci U S A
1 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Clin Res Hepatol Gastroenterol

  1. ALGOUD M, Tissot-Dupont H, Menard A, Botta-Fridlund D, et al
    Spontaneous clearance of chronic hepatitis C virus infection in HIV-positive patients, southeastern France.
    Clin Res Hepatol Gastroenterol. 2017 May 16. pii: S2210-7401(17)30096.
    PubMed     Text format    

    Dig Dis Sci

  2. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    PubMed     Text format     Abstract available

  3. LENCI I, Bosa A, Milana M, Baiocchi L, et al
    Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation.
    Dig Dis Sci. 2017 May 12. doi: 10.1007/s10620-017-4594.
    PubMed     Text format    

    Enferm Infecc Microbiol Clin

  4. PALLADINO C, Esteban-Cartelle B, Mate-Cano I, Sanchez-Carrillo M, et al
    Prevalence of relevant NS5A resistance-associated substitutions to elbasvir in genotype 1a hepatitis C virus patients in Spain.
    Enferm Infecc Microbiol Clin. 2017 May 15. pii: S0213-005X(17)30126.
    PubMed     Text format     Abstract available


  5. SAXENA V, Khungar V, Verna EC, Levitsky J, et al
    Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29258.
    PubMed     Text format     Abstract available

    J Viral Hepat

  6. OSIBOGUN O, Ogunmoroti O, Michos ED, Spatz ES, et al
    HIV/HCV Co-infection and the risk of Cardiovascular Disease: A Meta-analysis.
    J Viral Hepat. 2017 May 14. doi: 10.1111/jvh.12725.
    PubMed     Text format     Abstract available

  7. ROB B, Moreno C, Van Vlierberghe H, Bourgeois S, et al
    The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience.
    J Viral Hepat. 2017 May 15. doi: 10.1111/jvh.12726.
    PubMed     Text format     Abstract available

  8. MCLEOD A, Cullen BL, Hutchinson SJ, Roy KM, et al
    Limited Impact of Awareness-Raising Campaigns on Hepatitis C Testing Practices among General Practitioners.
    J Viral Hepat. 2017 May 14. doi: 10.1111/jvh.12724.
    PubMed     Text format     Abstract available

    J Virol

  9. WALTER S, Rasche A, Moreira-Soto A, Pfaender S, et al
    Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys.
    J Virol. 2016;91.
    PubMed     Text format     Abstract available

  10. SYED GH, Khan M, Yang S, Siddiqui A, et al
    Hepatitis C virus lipoviroparticles (HCV-LVP) assemble in the endoplasmic reticulum (ER) and bud off from the ER to Golgi in COPII vesicles.
    J Virol. 2017 May 17. pii: JVI.00499-17. doi: 10.1128/JVI.00499.
    PubMed     Text format     Abstract available

  11. LOGAN M, Law J, Wong JA, Hockman D, et al
    Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG.
    J Virol. 2016 Oct 19. pii: JVI.01552.
    PubMed     Text format     Abstract available

    Lancet Infect Dis

  12. ZHOU K, Fitzpatrick T, Walsh N, Kim JY, et al
    Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses.
    Lancet Infect Dis. 2016 Sep 5. pii: S1473-3099(16)30208.
    PubMed     Text format     Abstract available

    PLoS One

  13. D'ARMINIO MONFORTE A, Cozzi-Lepri A, Ceccherini-Silberstein F, De Luca A, et al
    Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.
    PLoS One. 2017;12:e0177402.
    PubMed     Text format     Abstract available

  14. AGGARWAL R, Chen Q, Goel A, Seguy N, et al
    Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.
    PLoS One. 2017;12:e0176503.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

    Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201704531.
    PubMed     Text format    

  16. OHASHI H, Koizumi Y, Fukano K, Wakita T, et al
    Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201705234.
    PubMed     Text format    


  17. BARBIER L, Cesaretti M, Dondero F, Cauchy F, et al
    Liver Transplantation With Older Donors: A Comparison With Younger Donors in a Context of Organ Shortage.
    Transplantation. 2016;100:2410-2415.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.